cytidine monophosphate has been researched along with Granulocytic Leukemia, Chronic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 8 (88.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arkoumani, E; Bourantas, K; Kalambokis, G; Kitsanou, M; Stefanou, D; V Tsianos, E | 1 |
| Arthur, C; Blacklock, H; Bradstock, K; Browett, P; Coulston, J; Gibson, J; Grigg, A; Hawkins, T; Herrmann, R; Hughes, T; Januszewicz, H; Low, C; Martin, N; Mollee, P; Morton, J; Rodwell, R; Schwarer, AP; Seldon, M; Seymour, JF; Shina, S; Spencer, A; Taylor, D; Taylor, KM; Watson, A; Wolf, M; Wright, S | 1 |
| Kamiya, K; Kawai, Y; Nakamura, T; Sugiyama, M; Tsutani, H; Ueda, T; Urasaki, Y; Wataya, S | 1 |
| Apfelbeck, U; Barbieri, G; Bechter, O; Duba, C; Eisterer, W; Gastl, G; Geissler, K; Kühr, T; Linkesch, W; Thaler, J; Zabernigg, A | 1 |
| Berger, U; Hehlmann, R; Hochhaus, A; Kuhn, C; Reiter, A | 1 |
| Antich, JL; Borrego, D; Brunet, S; Cervantes, F; Hernández-Boluda, JC; Martino, R; Montserrat, E; Sureda, A | 1 |
| del Cañizo, MC; Fisac, MP; Galende, J; Hurtado, JA; Moro, MJ; Rivas, JM; Rodriguez, JA; Tabernero, MD | 1 |
| Gotoh, A; Kawakubo, K; Kuriyama, Y; Miyazawa, K; Ohyashiki, K; Sashida, G; Uchida, Y | 1 |
| Abgrall, JF; Attal, J; Bauduer, F; Belhadj, K; Blanc, M; Brière, J; Cambier, N; Chabin, M; Chastang, C; Coso, D; Delain, M; Guerci, A; Guilhot, F; Guilhot, J; Guyotat, D; Harousseau, JL; Ifrah, N; Maloisel, F; Michallet, M; Morice, P; Pegourie-Bandelier, B; Reiffers, J; Rousselot, P; Solary, E; Tertain, G; Vilque, JP | 1 |
1 review(s) available for cytidine monophosphate and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
AraC-based pharmacotherapy of chronic myeloid leukaemia.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Clinical Trials as Topic; Cytarabine; Cytidine Monophosphate; Drug Administration Schedule; Guidelines as Topic; Humans; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Survival Analysis | 2001 |
4 trial(s) available for cytidine monophosphate and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Recombinant Proteins; Treatment Outcome | 2004 |
Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Pilot Projects; Recombinant Proteins; Treatment Outcome | 2000 |
Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Cytogenetic Analysis; Drug Resistance, Neoplasm; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pilot Projects; Treatment Outcome | 2001 |
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Prognosis; Recombinant Proteins; Risk Factors; Survival Rate | 2002 |
4 other study(ies) available for cytidine monophosphate and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Fulminant bronchiolitis obliterans organizing pneumonia following 2 d of treatment with hydroxyurea, interferon-alpha and oral cytarabine ocfosfate for chronic myelogenous leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cryptogenic Organizing Pneumonia; Cytidine Monophosphate; Fatal Outcome; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Male; Radiography, Thoracic; Tomography, X-Ray Computed | 2004 |
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Topics: Acute Disease; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Polycythemia Vera | 1994 |
Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study.
Topics: Adolescent; Adult; Aged; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Treatment Outcome | 2001 |
Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Blast Crisis; Bone Marrow; Cytidine Monophosphate; Cytogenetic Analysis; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Remission Induction | 2002 |